The anti-inflammatory mechanism of prostaglandin E2 receptor 4 activation in rat experimental autoimmune myocarditis

Journal of Cardiovascular Pharmacology

Volumn 57, Issue 3, 2011, Pages 365-372

  Ngoc, Pham Bao ^a   Suzuki, Jun Ichi ^b   Ogawa, Masahito ^b   Hishikari, Keiichi ^a   Takayama, Kiyoshi ^c   Hirata, Yasunobu ^b   Nagai, Ryozo ^d   Isobe, Mitsuaki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NB Health Laboratory   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

fibrosis; inflammation; prostaglandin; T cells

Indexed keywords

17,18,19,20 TETRANOR 16 (3 BIPHENYL) 2,3,13,14 TETRADEHYDRO PROSTAGLANDIN E1; FTA 2062; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; AREA UNDER THE CURVE; ARTICLE; AUTOIMMUNE MYOCARDITIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG HALF LIFE; DRUG INACTIVATION; GROWTH INHIBITION; HEART FUNCTION; IMMUNOMODULATION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MALE; MYOCARDITIS; MYOFIBROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RAT;

ALPROSTADIL; ANIMALS; ANTI-INFLAMMATORY AGENTS; AUTOIMMUNE DISEASES; CARDIOMYOPATHIES; CELL PROLIFERATION; DINOPROSTONE; DISEASE MODELS, ANIMAL; HEART; MALE; MYOCARDITIS; MYOSINS; RATS; RATS, INBRED LEW; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE; T-LYMPHOCYTES;

EID: 79952803862     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31820b7be1     Document Type: Article

References (37)

1. Blauwet LA, Cooper LT. Myocarditis. Prog Cardiovasc Dis. 2010;52: 274-288.
2. Cooper LT Jr. Myocarditis. N Engl J Med. 2009;360:1526-1538
3. Kawai C From myocarditis to cardiomyopathy: mechanism of in-flammation and cell death. Learning from the past for the future. Circulation. 1999;99:1091-1100. (Pubitemid 29104501)
4. Kodama M, Hanawa H, Saeki M, et al. Rat dilated cardiomyopathy after autoimmune giant cell myocarditis. Circ Res. 1994;75:278-284. (Pubitemid 24228320)
5. Takahashi T, Zhu SJ, Sumino H, et al. Inhibition of cyclooxygenase-2 enhances myocardial damage in a mouse model of viral myocarditis. Life Sci. 2005;78:195-204. (Pubitemid 41560972)
6. Ishiyama S, Hiroe M, Nishikawa T, et al. Nitric oxide contributes to the progression of myocardial damage in experimental autoimmune myocar-ditis in rats. Circulation. 1997;95:489-496. (Pubitemid 27056218)
7. Neu N, Rose NR, Beisel KW, et al. Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol. 1987;139:3630-3636. (Pubitemid 18013633)
8. Kodama M, Matsumoto Y, Fujiwara M, et al. A novel experimental model of giant cell myocarditis induced in rat by immunization with cardiac myosin fraction. Clin Imnnun Immunopathol. 1990;57:250-262. (Pubitemid 20368038)
9. Wegmann KW, Zhao W, Griffin AC, et al. Identification of myocarditogenic peptides derived from cardiac myosin capable of inducing experimental allergic myocarditis in the Lewis rat The utility of a class II binding motif in selecting self-reactive peptides. J Immunol. 1994;153:892-900.
10. Inomata T, Hanawa H, Miyanishi T, et al. Localization of porcine cardiac myosin epitope that induced experimental autoimmune myocarditis. Circ Res. 1995;76:726-733.
11. Takayama K, Garcia-Cardena G, Sukhova GK, et al. Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor. J Biol Chem. 2002;46:44147-44154. (Pubitemid 36157844)
12. Tilley SL, Coffman TM, Koller BH. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thrombox-anes. J Clin Invest. 2001;108:15-23. (Pubitemid 32634916)
13. Harris SG, Padilla J, Kouas L, et al. Prostaglandins as modulators of immunity. Trends Immunol. 2002;23:144-150. (Pubitemid 34178297)
14. Aronoff DM, Canetti C, Peters-Golden M. A prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP. JImmunol. 2004;173:559-565. (Pubitemid 38797384)
15. 2 receptor EP4 improves cardiac function after myocardial ischemia/reperfusion injury. Cardiovasc Res. 2009;81:123-132.
16. 2 receptor 4 activation in murine cardiac transplantation. Transplantation. 2009;87:1645-1653.
17. Shioi T, Kang PM, Douglas PS, et al. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J. 2000;19: 2537-2548. (Pubitemid 30323543)
18. Mori T, Chen YF, Feng JA, et al. Volume overload results in exaggerated cardiac hypertrophy in the atrial natriuretic peptide knockout mouse. Cardiovasc Res. 2004;61:771-779. (Pubitemid 38249476)
19. Futamatsu H, Suzuki J, Kosuge H, et al. Attenuation of experimental autoimmune myocarditis by blocking activated T cells through inducible costimulatory molecule pathway Cardiovasc Res. 2003;59:95-104. (Pubitemid 36776376)
20. Huber SA, Lodge PA. Coxsackievirus B3 myocarditis in BALB/c mice; evidence for autoimmunity to myocyte antigens. Am J Pathol. 1984;116: 21-29. (Pubitemid 14087090)
21. Seko Y, Shinkai Y Kawasaki A, et al. Expression of perforin in infiltrating cells in murine hearts with acute myocarditis caused by Coxackievirus B3. Circulation. 1991;84:788-795.
22. Suzuki J, Ogawa M, Futamatsu H, et al. A cyclooxygenase-2 inhibitor alters Th1/Th2 cytokine balance and suppresses autoimmune myocarditis in rats. J Mol Cell Cardiol. 2006;40:688-695.
23. Adams DH, Lloyd AR. Chemokines: leukocyte recruitment and activation cytokines. Lancet. 1997;349:490-495. (Pubitemid 27077839)
24. Smith SC, Allen PM. Myosin-induced acute myocarditis is a T cell mediated disease. J Immunol. 1991;147:2141-2147.
25. Pummerer C, Berger P, Fruhwirth M, et al. Cellular infiltrate, major histocompatibility antigen expression and immunopathogenic mech-anisms in cardiac myosin-induced myocarditis. Lab Invest. 1991;65: 538-547.
26. Kodama M, Matsumoto Y, Fujiwara M. In vivo lymphocyte-mediated myocardial injuries demonstrated by adoptive transfer of experimental autoimmune myocarditis. Circulation. 1992;85:1918-1926.
27. Penninger JM, Neu N, Timms E, et al. The induction of experimental autoimmune myocarditis in mice lacking CD4 or CD8 molecules. J Exp Med. 1993;178:1837-1842. (Pubitemid 23318467)
28. Suzuki J, Ogawa M, Futamatsu H, et al. Tea catechins improve left ventricular dysfunction, suppress myocardial inflammation, fibrosis, and alter cytokine expression in rat autoimmune myocarditis. Eur J Heart Fail. 2007;9:152-159. (Pubitemid 46402883)
29. Futamatsu H, Suzuki J, Mizuno S, et al. Hepatocyte growth factor ameliorates the progression of experimental autoimmune myocarditis: a potential role for induction of T helper 2 cytokines. Circ Res. 2005;96:823-830. (Pubitemid 40604965)
30. Katamura K, Shintaku N, Yamauchi Y et al. Prostaglandin E2 at priming of naive CD4+ T cells inhibits acquisition of ability to produce IFN-gammaandIL-2,butnotIL-4 andIL-5. JImmunol. 1995;155:4604-4612. (Pubitemid 3010794)
31. Demeure CE, Yang LP, Desjardins C, et al. Prostaglandin E2 primes naive T cells for the production of anti-inflammatory cytokines. Eur JImmunol. 1997;27:3526-3531. (Pubitemid 28018052)
32. Van der Pouw Kraan TC, Boeije LC, Smeenk RJ, et al. Prostaglandin-E2 is a potentinhibitor of human in terleukin 12 production. J Exp Med. 1995; 181:775-779.
33. Fedyk ER, Phipps RP. Prostaglandin E2 receptors of the EP2 and EP4 subtypes regulate activation and differentiation of mouse B lymphocytes to IgE-secreting cells. Proc Natl Acad Sci USA. 1996;93:10978-10983. (Pubitemid 26333103)
34. Shibata Y Henriksen RA, Honda I, et al. Splenic PGE2-releasing macrophages regulate Th1 and Th2 immune responses in mice treated with heat-killed BCG. JLeukoc Biol. 2005;78:1281-1290. (Pubitemid 41779234)
35. Murakami M, Kudo I. Prostaglandin E synthase: a novel drug target for inflammation and cancer. Curr Pharm Des. 2006;12:943-954.
36. Wuyts WA, Wanaudenaerde BM, Dupont LJ, et al. Modulation by cAMP of IL-1beta-induced eotaxin and MCP-1 expression and release in human airway smooth muscle cells. Eur Respir J. 2003;22:220-226. (Pubitemid 36986988)
37. Minami M, Shimizu K, Okamoto Y et al. Prostaglandin E receptor type 4-associated protein interacts directly with NF-kappaB1 and attenuates macrophage activation. J Biol Chem. 2008;283:9692-9703.